Is Douglas Emmett, Inc. overvalued or undervalued?

As of 5 September 2025, Douglas Emmett, Inc. has moved from a fair to very attractive valuation grade, indicating a significant improvement in its perceived value. The company appears to be undervalued based on its valuation ratios, including a P/E ratio of 56, a Price to Book Value of 1.46, and an EV to EBITDA of 4.54. In comparison, peers such as National Health Investors, Inc. have a P/E of 24.77, while SL Green Realty Corp. shows a much higher P/E of 731.77, highlighting Douglas Emmett's relative attractiveness.
Despite its recent struggles, with a year-to-date return of -11.69% compared to the S&P 500's 12.22%, the company's valuation metrics suggest it may offer significant upside potential. The PEG ratio of 0.28 further underscores its undervaluation relative to growth expectations, making it an appealing option for investors looking for value in the realty sector.